全文获取类型
收费全文 | 221904篇 |
免费 | 5369篇 |
国内免费 | 2392篇 |
专业分类
耳鼻咽喉 | 1579篇 |
儿科学 | 7255篇 |
妇产科学 | 4041篇 |
基础医学 | 21797篇 |
口腔科学 | 2947篇 |
临床医学 | 17927篇 |
内科学 | 38498篇 |
皮肤病学 | 1195篇 |
神经病学 | 19359篇 |
特种医学 | 10356篇 |
外国民族医学 | 13篇 |
外科学 | 33824篇 |
综合类 | 9260篇 |
现状与发展 | 5篇 |
一般理论 | 15篇 |
预防医学 | 21276篇 |
眼科学 | 3853篇 |
药学 | 13875篇 |
27篇 | |
中国医学 | 2646篇 |
肿瘤学 | 19917篇 |
出版年
2023年 | 522篇 |
2022年 | 785篇 |
2021年 | 1556篇 |
2020年 | 1285篇 |
2019年 | 1287篇 |
2018年 | 23211篇 |
2017年 | 18559篇 |
2016年 | 20649篇 |
2015年 | 2711篇 |
2014年 | 2973篇 |
2013年 | 3107篇 |
2012年 | 10044篇 |
2011年 | 24337篇 |
2010年 | 21076篇 |
2009年 | 13482篇 |
2008年 | 21848篇 |
2007年 | 24272篇 |
2006年 | 3025篇 |
2005年 | 4459篇 |
2004年 | 5459篇 |
2003年 | 6565篇 |
2002年 | 4441篇 |
2001年 | 1938篇 |
2000年 | 1725篇 |
1999年 | 1362篇 |
1998年 | 833篇 |
1997年 | 844篇 |
1996年 | 543篇 |
1995年 | 506篇 |
1994年 | 469篇 |
1993年 | 338篇 |
1992年 | 452篇 |
1991年 | 462篇 |
1990年 | 450篇 |
1989年 | 370篇 |
1988年 | 376篇 |
1987年 | 311篇 |
1986年 | 263篇 |
1985年 | 257篇 |
1984年 | 166篇 |
1983年 | 167篇 |
1982年 | 116篇 |
1980年 | 114篇 |
1979年 | 130篇 |
1978年 | 99篇 |
1977年 | 84篇 |
1975年 | 109篇 |
1974年 | 104篇 |
1970年 | 77篇 |
1969年 | 80篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
基于学生需求调查的预防医学专业毕业实习考核模式研究 《医学教育管理》2019,5(1):25-28
目的 以学生需求调查分析为基础,探索普通本科医学院校预防医学专业毕业实习考核模式。方法 采用分层整群抽样方法抽取昆明医科大学2012 级~ 2014 级的五年制本科预防医学专业310 名学生为研究对象,采用问卷和访谈提纲进行调查,内容主要包括对预防医学专业毕业实习考核内容、考核方式、考核主体等的认识、看法及评价。结果 92.81% 的学生认为需要由职业素养、综合知识、专业能力构成毕业实习考核内容,不同年级的学生对考核内容需求评价差异有统计学意义(P < 0.05);76.80% 的学生认为毕业实习考核方式可采用组合方式。访谈结果揭示,预防医学专业学生认同并愿接受内容更丰富、方式多样的毕业实习考核。结论 以多元化为导向构建预防医学专业的毕业实习考核模式,较适应预防医学人才培养的需要。 相似文献
22.
23.
Deissler Heidrun L. Lang Gerhard K. Lang Gabriele E. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2019,257(1):83-94
Graefe's Archive for Clinical and Experimental Ophthalmology - Intravitreal injection of the VEGF-binding protein aflibercept is widely used to treat various ocular diseases. In vitro,... 相似文献
24.
Hui Fan Xianzhen Jin Chunyan Liao Lina Qiao Wei Zhao 《Pathology, research and practice》2019,215(11):152667
MicroRNAs (miRNAs) have been found to be aberrantly expressed and exert essential roles in the tumorigenesis and progression of gastric cancer (GC). miR-301b-3p has been recognized as a cancer-related miRNA in lung cancer, bladder cancer and hepatocellular carcinoma. However, the function of miR-301b-3p in GC progression and its underlying mechanism have not been studied yet. In this study, we found that miR-301b-3p expression was up-regulated in GC tissues compared to adjacent noncancerous tissues. Furthermore, the elevated levels of miR-301b-3p were detected in GC cell lines (SGC-7901, AGS, MKN-45 and MGC-803) as compared with GES-1 cells. Interestingly, GC tissues from patients with tumor size ≥ 5 cm and advanced tumor stages showed obvious higher levels of miR-301b-3p compared to matched controls. Functionally, miR-301b-3p knockdown prominently inhibited cell proliferation, and induced cell cycle arrest at G1 phase and apoptosis in MGC-803 cells. Meanwhile, ectopic expression of miR-301b-3p conversely regulated these biological behaviors of MKN-45 cells. Next, we found that miR-301b-3p knockdown increased, whereas miR-301b-3p overexpression reduced the expression of zinc finger and BTB domain containing 4 (ZBTB4) in GC cells. Accordingly, luciferase reporter assay identified ZBTB4 as a direct target of miR-301b-3p. ZBTB4 overexpression markedly restrained the growth of MGC-803 cells. More importantly, ZBTB4 silencing partially reversed miR-301b-3p knockdown-induced tumor suppressive effects on MGC-803 cells. In conclusion, we firstly revealed that miR-301-3p was highly expressed in GC and contributed to tumor progression via attenuating ZBTB4, which might provide a novel molecular-targeted strategy for GC treatment. 相似文献
25.
26.
Despite a dramatic decrease in vertical transmission of HIV in the developed world, maternal HIV infection acquired after negative prenatal screening still leaves a window of vulnerability. Through quality assurance programs in two Canadian Provinces, five cases where perinatal HIV transmission occurred despite negative prenatal screening were identified between 2005 and 2015. Maternal risk factors such as intravenous drug use, high–risk sexual behavior, hepatitis C virus co–infection, and belonging to high prevalence minority groups were common. Two mothers had their negative HIV test performed in the first trimester and three mothers had negative testing in the third trimester. All babies were clinically healthy at delivery with a normal weight. Three babies were tested following subsequent identification of maternal HIV infection and two babies presented with opportunistic infections leading to their diagnoses. The characteristics of these cases suggest that to achieve complete elimination of vertical HIV transmission, selective and innovative clinical management of mothers at high risk for HIV may be required. 相似文献
27.
28.
目的:以HPLC法同时测定保健食品中非法添加的阿替洛尔、盐酸可乐定、氢氯噻嗪、盐酸哌唑嗪、卡托普利、利血平、硝苯地平、氨氯地平、尼群地平、尼莫地平、非洛地平和尼索地平。方法:HPLC法,采用Agilent Extend C18(4.6 mm × 250 mm,5 μm)色谱柱,以乙腈-0.2%磷酸溶液为流动相,梯度洗脱;流速:1.0 mL·min-1;柱温:35 ℃;检测波长:220 nm。结果:上述12个成分在各自线性范围内均线性良好,r均>0.996 9。平均回收率为94.8%~103.1%,RSD为0.89% ~ 1.7% (n=9)。结论:此法简便、准确、重复性好,可同时测定降压类保健食品中非法添加的12种化学成分。 相似文献
29.
Wen Chen Yun Zhao Xing Xie Jihong Liu Jingran Li Chao Zhao Shaoming Wang Xueyan Liao Qiong Shou Minghuan Zheng Alfred J Saah Lihui Wei Youlin Qiao 《Vaccine》2019,37(6):889-897
Background
A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has demonstrated efficacy and acceptable safety in international studies. However, these studies did not include participants from mainland China, which has a substantial burden of HPV-related disease. This is the first safety report with a follow-up period of up to 90?months from a randomized, double-blind, placebo-controlled trial of qHPV vaccine in Chinese women 20–45?years of age.Methods
Participants were randomized 1:1 to receive three doses of qHPV vaccine or placebo (Day 1, Month 2, and Month 6). Efficacy outcomes are reported elsewhere. Injection-site and systemic adverse events (AEs) were collected using vaccination report cards (VRCs) for 15?days following each vaccination. Serious AEs (SAEs), pregnancy outcomes, new medical conditions, and fetal/infant SAEs were collected during the entire study.Results
Of 3006 participants randomized, AEs were reported by 926 (61.8%) qHPV vaccine recipients and 856 (57.1%) placebo recipients over the entire study. Four participants (two in each group) discontinued the study vaccination due to AEs that were considered vaccination-related. Within 15?days following any vaccination, injection-site AEs prompted for on the VRC were more frequent among qHPV vaccine recipients (37.6% vs 27.8%), and systemic AEs prompted for on the VRC were similar in frequency between qHPV vaccine and placebo groups (46.8% vs 45.1%). Thirty-eight and 43 participants reported SAEs in qHPV vaccine and placebo groups, respectively. No SAE was considered qHPV vaccine-related. Pregnancy outcomes, fetal/infant SAEs, and new medical conditions were generally similar in frequency between the qHPV vaccine and placebo groups, and within normal ranges.Conclusion
The qHPV vaccine was well tolerated and demonstrated a favorable safety profile in Chinese women 20–45?years of age, consistent with findings from global trials and safety surveillance studies.Trial registration: clinicaltrials.gov; NCT00834106. 相似文献30.
[目的]明确自发性高血压大鼠(SHR)脑损害与RhoA、ROCK-1的相关性,探讨针刺干预SHR脑保护的Rho通路机制。[方法]将SHR随机分为模型对照组、太冲穴组,WKY大鼠设为正常对照组。太冲穴组针刺干预4周,其余两组在干预期内给予相同程度、相同时长的抓取。观测各组大鼠收缩压、舒张压、平均动脉压的改变;苏木精-伊红(HE)染色观察脑组织形态学改变;蛋白免疫印迹(Western blot)法测定各组大鼠脑组织中RhoA、ROCK-1的表达水平。[结果]在干预周期内,正常对照组收缩压、舒张压、平均压均处于正常血压范围内。与正常对照组比较,模型对照组收缩压、舒张压、平均压均较高,且有随着周龄增加而增高的趋势。与模型对照组相比,太冲穴组可有效降低收缩压,有降低舒张压、平均压的趋势。模型对照组较正常对照组脑组织细胞排列紊乱,细胞坏死及间质水肿程度加重,RhoA、ROCK-1表达升高;太冲穴组与模型对照组比较,脑细胞排列规则,细胞坏死及间质水肿消失,RhoA、ROCK-1表达下降。[结论]针刺太冲穴能有效降低SHR血压,改善脑损害,其机制可能与抑制RhoA/ROCK-1信号通路表达相关。 相似文献